Cellectar Biosciences, Inc.
Cellectar Biosciences, Inc. (CLRB) Insider Trading
Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.
SEC EDGAR · FMP · CLRB · as of Jun 9, 2026
Activity summary
Buy transactions
7
P-Purchase only
Sell transactions
0
12 Months
Buy/Sell ratio
∞
Buy/Sell (by trades)
Overall sentiment
Cellectar Biosciences, Inc. insiders have been net buyers of shares over the past 12 Months, which may signal confidence in the company's outlook.
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only
As of Jun 9, 2026
CLRB insider buying and selling by quarter
CLRB insider selling · CLRB insider buying stocks · quarterly insider activity
Mobile shows last 4Q · Desktop shows full 8Q
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters
As of Jun 9, 2026
Active insiders
Most active in past 12 months · CLRB ceo insider trading
Showing all insiders · Click a card to filter the transactions table below
▸ Aggregated from reportingName · top 5 by trade count (12M) · no extra API
Recent insider transactions
CLRB executive sell shares · CLRB board member insider trading · CLRB insider trading SEC filing
Scroll horizontally to see all columns
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| May 7, 2026 | Longcor Jarrod COO | Purchase | 8,680 | $25K | Form 4 |
| May 7, 2026 | CARUSO JAMES V CEO · Director | Purchase | 8,680 | $25K | Form 4 |
| Dec 12, 2025 | NEIS JOHN Director | Sale | 198 | $732 | Form 4 |
| Jul 2, 2025 | CARUSO JAMES V CEO · Director | Purchase | 10,000 | $50K | Form 4 |
| Jul 2, 2025 | Longcor Jarrod COO | Purchase | 10,000 | $50K | Form 4 |
| Jul 2, 2025 | Kolean Chad J CFO | Purchase | 5,000 | $25K | Form 4 |
| Jan 10, 2025 | Longcor Jarrod COO | Purchase | 30,000 | $8K | Form 4 |
| Dec 8, 2023 | Lea Darrell Shane Chief Commercial Officer | Award | 39,599 | — | Form 4 |
| Dec 8, 2023 | Kolean Chad J CFO | Award | 42,554 | — | Form 4 |
| Dec 8, 2023 | Shustov Andrei Senior Vice President, Medical | Award | 47,856 | — | Form 4 |
| Dec 8, 2023 | Longcor Jarrod COO | Award | 42,927 | — | Form 4 |
| Dec 8, 2023 | CARUSO JAMES V President and CEO · Director | Award | 40,596 | — | Form 4 |
| Sep 14, 2021 | Swirsky Douglas J Director | Purchase | 25,000 | $26K | Form 4 |
| Sep 3, 2021 | DRISCOLL FREDERICK W Director | Purchase | 19,417 | $20K | Form 4 |
| Mar 4, 2021 | CARUSO JAMES V President and CEO · Director | Purchase | 5,100 | $9K | Form 4 |
| Dec 28, 2020 | CARUSO JAMES V President and CEO · Director | Purchase | 37,037 | $50K | Form 4 |
| Dec 28, 2020 | Longcor Jarrod Chief Business Officer | Purchase | 29,630 | $40K | Form 4 |
| Dec 28, 2020 | Elefant Dov CFO | Purchase | 7,407 | $10K | Form 4 |
| Jun 4, 2020 | HILL STEPHEN A Director | Purchase | 18,000 | $19K | Form 4 |
| Jun 5, 2020 | Elefant Dov CFO | Purchase | 4,348 | $5K | Form 4 |
| Jun 5, 2020 | Longcor Jarrod Chief Business Officer | Purchase | 65,218 | $75K | Form 4 |
| Jun 5, 2020 | CARUSO JAMES V President and CEO · Director | Purchase | 21,740 | $25K | Form 4 |
Lea Darrell Shane
Chief Commercial Officer
Date
Dec 8
Shares
39,599
Price
—
Value
—
Shustov Andrei
Senior Vice President, Medical
Date
Dec 8
Shares
47,856
Price
—
Value
—
CARUSO JAMES V
President and CEO · Director
Date
Dec 8
Shares
40,596
Price
—
Value
—
CARUSO JAMES V
President and CEO · Director
Date
Mar 4
Shares
5,100
Price
$1.70
Value
$9K
CARUSO JAMES V
President and CEO · Director
Date
Dec 28
Shares
37,037
Price
$1.35
Value
$50K
Longcor Jarrod
Chief Business Officer
Date
Dec 28
Shares
29,630
Price
$1.35
Value
$40K
Longcor Jarrod
Chief Business Officer
Date
Jun 5
Shares
65,218
Price
$1.15
Value
$75K
CARUSO JAMES V
President and CEO · Director
Date
Jun 5
Shares
21,740
Price
$1.15
Value
$25K
▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —
About CLRB insider trading
CLRB insider trades
Cellectar Biosciences, Inc. (CLRB) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including Longcor Jarrod (COO), CARUSO JAMES V (CEO · Director), NEIS JOHN (Director). Over the past 12 months, 4 insiders have filed transactions with the SEC. CLRB insiders have been primarily buying, which may reflect pre-scheduled Rule 10b5-1 plan executions.
For Cellectar Biosciences, Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →
Frequently asked questions
CLRB insider trading · 5 questionsThe insiders of Cellectar Biosciences, Inc. (CLRB) include executives and directors such as Longcor Jarrod (COO), CARUSO JAMES V (CEO · Director), NEIS JOHN (Director), among others. Over the past 12 months, 4 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.
▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 9, 2026